Moberg Pharma AB (SE0020353928) — research page
SE · se-cm-kg/XSTO/SE0020353928 · as of 2026-11-06
Identity and listing
The issuer is Moberg Pharma AB, listed on Nasdaq Stockholm under ticker SE0020353928, with ISIN SE0020353928 and LEI 549300XFXK7DVGDRP410. Its security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Moberg Pharma AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0020353928 | source · 2026-11-06 |
| ISIN | SE0020353928 | source · 2026-11-06 |
| LEI | 549300XFXK7DVGDRP410 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 38 filings on 18 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 14 days, and the latest filing is 3 days before the record date of 2026-11-06. The latest filing is dated 2026-11-03 and is of type Inside information. Nasdaq Stockholm carries a median of 30.0 filings, a median cadence gap of 9.5 days and a median latency of 7.0 days across 398 issuers. The sector median for SE is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 38 | 14 | 3 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-03 | Inside information | Inside information | Moberg Pharma granted U.S. patent relating to improved dosing of MOB-015 |
| 2026-11-03 | Inside information | Inside information | Moberg Pharma beviljas amerikanskt patent avseende förbättrad dosering av MOB-015 |
| 2026-10-20 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Moberg Pharmas valberedning utsedd |
| 2026-10-20 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Moberg Pharma's Nomination Committee appointed |
| 2026-10-05 | Investor News | Investor News | New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes for this register.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move lines for this register, as the index holds no lifecycle type map for SE. The halt flag is listed, not halted.
Orderability
The outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1, because the chapter as of 2026-11-04 carries no client categories. The outcome therefore cannot name its client category.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
One research house is named on the issuer's own investor-relations page: Redeye.
| research house | analyst | source · read date |
|---|---|---|
| Redeye | Jessica Grunewald | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0020353928 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.mobergpharma.se/sv/investerare/analytiker (coverage)
- 10.7
- https://mcp.se-cm-kg.ai/record/XSTO/SE0020353928 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0020353928"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:b833e1e320bded34.